Gilead Sciences Inc (GILD)

66.87
+1.10(+1.67%)
Pre Market
66.82
-0.05(-0.07%)
- Real-time Data
  • Volume:
    7,715,858
  • Bid/Ask:
    66.70/66.83
  • Day's Range:
    65.86 - 67.09

GILD Overview

Prev. Close
66.87
Day's Range
65.86 - 67.09
Revenue
24.69B
Open
66.02
52 wk Range
56.56 - 85.67
EPS
0.06
Volume
7,715,858
Market Cap
84.19B
Dividend (Yield)
2.84 (4.32%)
Average Vol. (3m)
8,071,948
P/E Ratio
1,173.98
Beta
0.42
1-Year Change
-20.38%
Shares Outstanding
1,259,056,043
Next Earnings Date
Apr 29, 2021
What is your sentiment on Gilead Sciences Inc?
or
Market is currently closed. Voting is open during market hours.

Gilead Sciences Inc News

Gilead Sciences Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuyStrong BuyBuy
Technical IndicatorsStrong SellBuyStrong BuyStrong BuyStrong Sell
SummaryNeutralBuyStrong BuyStrong BuyNeutral

Gilead Sciences Inc Company Profile

Gilead Sciences Inc Company Profile

Employees
13600

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Read More
  • look at Regeneron, on Squawk Ally. Twice the reporter came at him in two different way about cost and every day people being able to receive their drug and their CFO refused to address the affordable of their drug, he said it's up to doctors, the states, and the government to ensure they get the best possible treatment for people.
    3
    • Gild was never trash... just weak management at the point of attack. Rendeservir (forgive my spelling) is still the most used therapeutic out there.. Every person I've known who contracted Covid-19 have been treated in the hospital around here and in South Fla with it... leadership should of capitalized on the foundation they built... just my 2 cents
      0
      • let's go. lets see 60 today!
        8
        • $78 by End of next week?! Agree?
          2
          • Jack Leethanks for that prediction but i will have probably sold by then. Im guessing you are a bot or are trying to buy this cheap stock at an even cheaper price.
            2
          • But if Gilead keeps pumping out cures for diseases maybe i will live to see 2090.
            0
          • How you can know it?
            0
        • most solid investment right now
          1
          • yes, eat your money slowly
            4
          • Jack Leei hope you didnt short at $58 because then you will have been eating your money slowly. Looser
            0
        • It looks like its not going anywhere, but it’s solid investment
          3
          • go disappeared
            2
        • sold, ****trash
          3
          • sorry for your loss.
            0
          • nah, I bought UAL with 45 dollar per-share after I sold this. I wish I sold earlier. this trash stock waste my time.
            0
        • man. thus stock is crazy
          0
          • PharmaMar's antiviral is 100 times more effective against Covid-19 than other treatments, reducing its viral load by almost 100%
            0
            • Gilead is a good share .  will go higher for sure.!
              2
              • https://invst.ly/tqicz
                1
                • https://invst.ly/tr34y
                  0
                • https://invst.ly/tr4ab
                  0
              • I think we should see $84 by June this year, but I don’t think it’s going be higher until they start to get profits from new cancer drugs. Anyway, probably next year can be game changer for the stock.
                1
                • Pfizer Drops India Vaccine Application After Regulator Seeks Local Trial - Reuters. I guess pfizer doesnt care about Indians well being... or the vacine is a fraud. Dont worry gilead gave them Veklury. Thanks but no thanks Pfizer.
                  1
                  • when is the dividend date?
                    2
                    • Guys and girls, what did I said? 2021 gonna be the beginning of strong moving year for Gilead, hop on the train now before it’s gonna be late.
                      0
                      • EPS earning good!
                        0
                        • $75 next week
                          1
                          • The conference call is at 430pm but when is the earning release?
                            0
                            • during the conference
                              0
                          • Great news https://finance.yahoo.com/news/gilead-sciencess-earnings-outlook-151440708.html Remenber after earnings often stock flet but by the half of february the stock will reach 75 usd and dont forget MORGAN STANLEY 83 usd TARGET https://www.barrons.com/articles/2-reasons-this-will-be-gileads-year-says-morgan-stanley-51611082220
                            1
                            • This is worse than watching KHC
                              0
                              • lol, this stock sacks
                                9
                                • Thank you Morgan Stanley to 83
                                  1
                                  • Calm down guys. You gonna regret if you are selling. 2021 will be a good year. Just wait to the first earning and you will see the devellopment.
                                    2
                                    • Sell it and run away, this is probably the last days we ever see this stock above 60
                                      12
                                      • why do you think so?
                                        0
                                      • Look how hopeless the 5y graps looks. And if the price falls below 57, then god knows where the bottom is. $30? $20? I wouldn’t want to risk.
                                        1
                                      • why didn't you get in at $57.50-58.50 range, target 70-80 range and stop at 56.9? can you doing better that this risk rewards anywhere? anyways it's gone now. I am long in GILD and target is $75
                                        0
                                    • GILD management team, WS wants to know your future, but you told them what you were in the past year. That won't work, grow up!
                                      3
                                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.